Apollo Univ PhD Clinical Research FAQs
Ques. What is the minimum and maximum duration of the Ph.D. in Clinical Research at The Apollo University?
Ans. The Ph.D. programme at The Apollo University follows UGC regulations. For full-time scholars, the minimum duration is 3 years and the maximum is 6 years from the date of registration. For part-time scholars, the minimum duration is 4 years and the maximum is 6 years. Extensions beyond the maximum duration require special approval from the university. Scholars are expected to complete their coursework in the first year, submit a research proposal, and then proceed with their research work under the guidance of an approved supervisor.
Ques. Is it possible to pursue Ph.D. in Clinical Research at TAU while working full-time in a hospital or research organisation?
Ans. Yes, The Apollo University offers the Ph.D. in both Full-Time and Part-Time modes. The Part-Time mode is specifically designed for working professionals who wish to pursue doctoral research alongside their professional commitments. The annual fee for part-time mode is Rs 50,000 per annum (compared to Rs 20,000 for full-time). Part-time scholars are required to spend a minimum number of days on campus for coursework, seminars, and research activities as per UGC norms. Given TAU's location within the Apollo Knowledge City and its affiliation with Apollo Hospitals, working professionals in the Apollo ecosystem may find it particularly convenient to pursue part-time research.
Ques. What research areas are available under Clinical Research at TAU, and how is a supervisor assigned?
Ans. Under the Faculty of Health Sciences, Ph.D. in Clinical Research at TAU covers a broad range of research areas including clinical trials, pharmacovigilance, biostatistics, epidemiology, public health research, health informatics, patient outcomes research, and evidence-based medicine. Research areas are not strictly restricted to those listed, and candidates may propose their own research topic in the application. Supervisors are assigned based on the candidate's research proposal and the availability of faculty with matching expertise. Candidates are encouraged to review the faculty profiles on the TAU website (apollouniversity.edu.in/academics/faculty/) before applying to identify potential supervisors.
Ques. Does TAU-RET exemption apply if I have a UGC-NET qualification but not JRF? What documents are needed?
Ans. Yes, candidates with a valid UGC-NET qualification (even without JRF) may be considered for exemption from the TAU-RET entrance examination, as per the university's admission policy. Similarly, CSIR-NET, ICMR-JRF, DBT-JRF, and other national-level research fellowships/qualifications may also be considered for exemption. To claim this exemption, candidates must submit a copy of their valid NET/JRF certificate along with the application form. The final decision on exemption rests with the university's admission committee. Candidates are advised to mention their NET/JRF qualification clearly in the application and contact the Directorate of Research for confirmation.
Ques. What is the difference between the Cycle 1 and Cycle 2 admissions? Is one cycle better than the other for Clinical Research?
Ans. TAU conducts Ph.D. admissions in two cycles annually: Cycle 1 (March-May) and Cycle 2 (October-December). Both cycles follow the same selection process (TAU-RET, interview, and research proposal evaluation) and offer the same programme. The primary difference is the batch start date - Cycle 1 scholars begin in May and Cycle 2 scholars begin in December. For Clinical Research, both cycles are equally valid. However, Cycle 1 may be preferred by candidates who have recently completed their postgraduate examinations (results typically declared by February-March), while Cycle 2 suits candidates who need more time to prepare their research proposal or secure a supervisor. There is no difference in the quality of supervision or research facilities between the two cycles.
Ques. Are there any publications or conference presentation requirements during the Ph.D. programme at TAU?
Ans. As per UGC regulations (UGC Regulations 2022), Ph.D. scholars are required to present at least one research paper at a conference or seminar before the submission of the thesis. Additionally, scholars are encouraged (though not always mandated) to publish at least one research paper in a UGC-CARE listed or peer-reviewed journal before thesis submission. The Apollo University, being a research-oriented institution with access to the Apollo Hospitals clinical ecosystem, provides scholars with opportunities to publish in health sciences journals and present at national and international conferences. The Directorate of Research at TAU actively supports scholars in identifying publication and conference opportunities relevant to their research domain.







Comments